Tuesday, October 24, 2017 3:25:28 PM
(Sure it could dip down based on events such as slower revenues this quarter and during the 4th quarter, but I see these occurrences as a buying opportunity. It may also dip based on raising capital in late 4th quarter to early 1st quarter 2018.)
I look to partnerships first, then milestones, then revenue growth in regards to a steady and strong upward trend throughout the remainder of 2017 and full year 2018.
(Take a few minutes to listen to the latest presentation, and it should make you extremely confident and comfortable, if you end up holding your position for an extended time.)
I wouldn't expend too much energy on dips throughout the rest of the year, as we may be just experiencing "tax loss selling" due to the massive spike last December. Some players may want to offset as the year closes out.
If we do see a near term spike, it's up to you in how you handle it based upon your goals as an investor. Best of luck.
Recent OPGN News
- OpGen Provides Update on Business Operations and Strategic Opportunities • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K • GlobeNewswire Inc. • 04/23/2024 08:15:00 PM
- Shares Rip In Reaction To Activist Investor Becoming CEO • AllPennyStocks.com • 03/26/2024 08:20:00 PM
- OpGen Announces Acquisition of Preferred Stock by David Lazar • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 12:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:58:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:37:15 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/24/2023 05:15:18 AM
- OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 09:59:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:30:09 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:18:03 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/13/2023 09:17:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:15:31 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:14:21 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:13:12 PM
- OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds • GlobeNewswire Inc. • 10/12/2023 04:32:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:40:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:10 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/28/2023 08:24:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:30:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM